ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,744,457 | -24.5% | 1,971,460 | -7.0% | 0.00% | -20.0% |
Q2 2023 | $14,222,577 | -29.3% | 2,119,609 | -7.0% | 0.01% | -28.6% |
Q1 2023 | $20,125,424 | +94.5% | 2,279,210 | +68.3% | 0.01% | +75.0% |
Q4 2022 | $10,347,868 | +19.7% | 1,354,433 | +11.6% | 0.00% | +33.3% |
Q3 2022 | $8,644,000 | +26.7% | 1,213,915 | +44.0% | 0.00% | +50.0% |
Q2 2022 | $6,820,000 | -82.9% | 843,076 | -70.7% | 0.00% | -83.3% |
Q1 2022 | $39,945,000 | -41.4% | 2,877,843 | +18.5% | 0.01% | -36.8% |
Q4 2021 | $68,143,000 | -9.6% | 2,428,460 | +9.5% | 0.02% | -13.6% |
Q3 2021 | $75,415,000 | -14.1% | 2,218,729 | +3.3% | 0.02% | -15.4% |
Q2 2021 | $87,781,000 | -3.3% | 2,148,319 | -4.7% | 0.03% | -7.1% |
Q1 2021 | $90,744,000 | -47.0% | 2,253,948 | -22.1% | 0.03% | -49.1% |
Q4 2020 | $171,195,000 | +19.2% | 2,895,244 | -1.9% | 0.06% | +5.8% |
Q3 2020 | $143,571,000 | +32.5% | 2,952,304 | +31.9% | 0.05% | +20.9% |
Q2 2020 | $108,322,000 | +161.9% | 2,238,984 | +50.4% | 0.04% | +115.0% |
Q1 2020 | $41,354,000 | +28.9% | 1,488,657 | +38.9% | 0.02% | +66.7% |
Q4 2019 | $32,072,000 | +93.5% | 1,071,945 | +99.9% | 0.01% | +71.4% |
Q3 2019 | $16,574,000 | -45.1% | 536,374 | -14.2% | 0.01% | -41.7% |
Q2 2019 | $30,188,000 | – | 625,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
Triatomic Management LP | 130,805 | $999,350 | 0.84% |
Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |